Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Collapse of the Plasmacytoid Dendritic Cell Compartment in Advanced Cutaneous Melanomas by Components of the Tumor Cell Secretome.

Vescovi R, Monti M, Moratto D, Paolini L, Consoli F, Benerini L, Melocchi L, Calza S, Chiudinelli M, Rossi G, Bugatti M, Maio M, Fonsatti E, Farisoglio C, Simbolo M, Almici C, Verardi R, Scarpa A, Bergese P, Manganoni A, Facchetti F, Vermi W.

Cancer Immunol Res. 2019 Jan;7(1):12-28. doi: 10.1158/2326-6066.CIR-18-0141. Epub 2018 Nov 6. Erratum in: Cancer Immunol Res. 2019 Apr;7(4):693.

PMID:
30401679
2.

Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.

Camisaschi C, De Filippo A, Beretta V, Vergani B, Villa A, Vergani E, Santinami M, Cabras AD, Arienti F, Triebel F, Rodolfo M, Rivoltini L, Castelli C.

J Invest Dermatol. 2014 Jul;134(7):1893-1902. doi: 10.1038/jid.2014.29. Epub 2014 Jan 17.

3.

Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL.

Aspord C, Leccia MT, Charles J, Plumas J.

Cancer Immunol Res. 2013 Dec;1(6):402-15. doi: 10.1158/2326-6066.CIR-13-0114-T. Epub 2013 Sep 26.

4.

Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer.

Wagner F, Hölig U, Wilczkowski F, Plesca I, Sommer U, Wehner R, Kießler M, Jarosch A, Flecke K, Arsova M, Tunger A, Bogner A, Reißfelder C, Weitz J, Schäkel K, Troost EGC, Krause M, Folprecht G, Bornhäuser M, Bachmann MP, Aust D, Baretton G, Schmitz M.

Front Immunol. 2019 Mar 29;10:602. doi: 10.3389/fimmu.2019.00602. eCollection 2019.

5.

Natural human plasmacytoid dendritic cells induce antigen-specific T-cell responses in melanoma patients.

Tel J, Aarntzen EH, Baba T, Schreibelt G, Schulte BM, Benitez-Ribas D, Boerman OC, Croockewit S, Oyen WJ, van Rossum M, Winkels G, Coulie PG, Punt CJ, Figdor CG, de Vries IJ.

Cancer Res. 2013 Feb 1;73(3):1063-75. doi: 10.1158/0008-5472.CAN-12-2583. Epub 2013 Jan 23.

6.

Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity.

Guéry L, Hugues S.

Front Immunol. 2013 Mar 6;4:59. doi: 10.3389/fimmu.2013.00059. eCollection 2013.

7.

MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity.

Sage AP, Murphy D, Maffia P, Masters LM, Sabir SR, Baker LL, Cambrook H, Finigan AJ, Ait-Oufella H, Grassia G, Harrison JE, Ludewig B, Reith W, Hansson GK, Reizis B, Hugues S, Mallat Z.

Circulation. 2014 Oct 14;130(16):1363-73. doi: 10.1161/CIRCULATIONAHA.114.011090. Epub 2014 Sep 15.

8.

Impaired interferon-alpha production by plasmacytoid dendritic cells after cord blood transplantation in children: implication for post-transplantation toll-like receptor ligand-based immunotherapy.

Charrier E, Cordeiro P, Brito RM, Harnois M, Mezziani S, Herblot S, Le Deist F, Duval M.

Biol Blood Marrow Transplant. 2014 Oct;20(10):1501-7. doi: 10.1016/j.bbmt.2014.06.007. Epub 2014 Aug 14.

9.

Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma.

Chevolet I, Speeckaert R, Schreuer M, Neyns B, Krysko O, Bachert C, Van Gele M, van Geel N, Brochez L.

J Transl Med. 2015 Jan 16;13:9. doi: 10.1186/s12967-014-0376-x.

10.

Plasmacytoid dendritic cells prime IFN-gamma-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions.

Salio M, Cella M, Vermi W, Facchetti F, Palmowski MJ, Smith CL, Shepherd D, Colonna M, Cerundolo V.

Eur J Immunol. 2003 Apr;33(4):1052-62.

11.

Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.

Han N, Zhang Z, Liu S, Ow A, Ruan M, Yang W, Zhang C.

Arch Oral Biol. 2017 Jun;78:129-134. doi: 10.1016/j.archoralbio.2017.02.012. Epub 2017 Feb 10.

PMID:
28242507
12.

Potential role of plasmacytoid dendritic cells for FOXP3+ regulatory T cell development in human colorectal cancer and tumor draining lymph node.

Gai XD, Song Y, Li C, Lei YM, Yang B.

Pathol Res Pract. 2013 Dec;209(12):774-8. doi: 10.1016/j.prp.2013.08.011. Epub 2013 Sep 6.

PMID:
24080284
13.

Tolerogenic Plasmacytoid Dendritic Cells Control Paracoccidioides brasiliensis Infection by Inducting Regulatory T Cells in an IDO-Dependent Manner.

Araújo EF, Medeiros DH, Galdino NA, Condino-Neto A, Calich VL, Loures FV.

PLoS Pathog. 2016 Dec 19;12(12):e1006115. doi: 10.1371/journal.ppat.1006115. eCollection 2016 Dec.

14.

Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease.

Scott JL, Wirth JR, EuDaly JG, Gilkeson GS, Cunningham MA.

Clin Immunol. 2017 Feb;175:109-114. doi: 10.1016/j.clim.2016.12.009. Epub 2016 Dec 30.

PMID:
28041989
15.

Plasmacytoid dendritic cells contribute to doxorubicin-induced tumor arrest in a mouse model of pulmonary metastasis.

Terlizzi M, Popolo A, Pinto A, Sorrentino R.

J Immunother. 2014 May;37(4):214-24. doi: 10.1097/CJI.0000000000000026.

PMID:
24714355
16.

Plasmacytoid dendritic cells play a key role in tumor progression in lipopolysaccharide-stimulated lung tumor-bearing mice.

Rega A, Terlizzi M, Luciano A, Forte G, Crother TR, Arra C, Arditi M, Pinto A, Sorrentino R.

J Immunol. 2013 Mar 1;190(5):2391-402. doi: 10.4049/jimmunol.1202086. Epub 2013 Jan 25.

17.

Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer.

Hartmann E, Wollenberg B, Rothenfusser S, Wagner M, Wellisch D, Mack B, Giese T, Gires O, Endres S, Hartmann G.

Cancer Res. 2003 Oct 1;63(19):6478-87.

18.

HMGB1 secretion during cervical carcinogenesis promotes the acquisition of a tolerogenic functionality by plasmacytoid dendritic cells.

Demoulin S, Herfs M, Somja J, Roncarati P, Delvenne P, Hubert P.

Int J Cancer. 2015 Jul 15;137(2):345-58. doi: 10.1002/ijc.29389. Epub 2014 Dec 27.

19.

S1PR4 is required for plasmacytoid dendritic cell differentiation.

Dillmann C, Mora J, Olesch C, Brüne B, Weigert A.

Biol Chem. 2015 Jun;396(6-7):775-82. doi: 10.1515/hsz-2014-0271.

PMID:
25720060
20.

Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs.

Yoneyama H, Matsuno K, Toda E, Nishiwaki T, Matsuo N, Nakano A, Narumi S, Lu B, Gerard C, Ishikawa S, Matsushima K.

J Exp Med. 2005 Aug 1;202(3):425-35.

Supplemental Content

Support Center